Study of Low-Dose Cytarabine in Combination With Arsenic Trioxide, Compared With Low-Dose Cytarabine Alone, for the Treatment of Elderly Patients With Acute Myeloid Leukemia - Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00513305

Contacts


Contact: Cephalon Contact	1-877-CEPH-TRY

Locations


United States, California
	USC / Norris Cancer Hospital	Recruiting
	Los Angeles, California, United States, 90033
	Contact: Site Contact
	Principal Investigator: Dan Douer, MD
	UCLA Medical Center	Recruiting
	Los Angeles, California, United States, 90095
	Contact: Site Contact
	Principal Investigator: Gary Schiller, MD

United States, Illinois
	University of Illinois	Not yet recruiting
	Chicago, Illinois, United States, 60612
	Contact: Site Contact
	Principal Investigator: John G. Quigley, MD

United States, Indiana
	Indiana Oncology Hematology Consultants	Recruiting
	Indianapolis, Indiana, United States, 46202
	Contact: Site Contact
	Principal Investigator: Maureen Cooper, MD

United States, New York
	Weill Medical College of Cornell University	Recruiting
	New York, New York, United States, 10021
	Contact: Site Contact
	Principal Investigator: Gail Roboz, MD
	Roswell Park Cancer Institute	Recruiting
	Buffalo, New York, United States, 14263
	Contact: Site Contact
	Principal Investigator: Meir Wetzler, MD

United States, North Carolina
	Brody School of Medicine	Recruiting
	Greenville, North Carolina, United States, 27834
	Contact: Site Contact
	Principal Investigator: Adam Asch, MD

United States, Oklahoma
	University of Oklahoma	Not yet recruiting
	Oklahoma City, Oklahoma, United States, 73104
	Contact: Site Contact
	Principal Investigator: Jennifer Holter, MD

United States, South Carolina
	Medical University of South Carolina	Not yet recruiting
	Charleston, South Carolina, United States, 29425
	Contact: Site Contact
	Principal Investigator: Robert K. Stuart, MD

Sponsors and Collaborators

Cephalon